199 related articles for article (PubMed ID: 11427521)
1. Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor.
Murphy JF; Fitzgerald DJ
FASEB J; 2001 Jul; 15(9):1667-9. PubMed ID: 11427521
[No Abstract] [Full Text] [Related]
2. The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase.
Akarasereenont PC; Techatraisak K; Thaworn A; Chotewuttakorn S
Mediators Inflamm; 2002 Feb; 11(1):17-22. PubMed ID: 11926591
[TBL] [Abstract][Full Text] [Related]
3. Role of VEGF-flt receptor system in normal and tumor angiogenesis.
Shibuya M
Adv Cancer Res; 1995; 67():281-316. PubMed ID: 8571818
[No Abstract] [Full Text] [Related]
4. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
Zeng H; Sanyal S; Mukhopadhyay D
J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells.
Bryant CE; Appleton I; Mitchell JA
Life Sci; 1998; 62(24):2195-201. PubMed ID: 9627078
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent.
Bernatchez PN; Soker S; Sirois MG
J Biol Chem; 1999 Oct; 274(43):31047-54. PubMed ID: 10521504
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.
Parenti A; Morbidelli L; Cui XL; Douglas JG; Hood JD; Granger HJ; Ledda F; Ziche M
J Biol Chem; 1998 Feb; 273(7):4220-6. PubMed ID: 9461619
[TBL] [Abstract][Full Text] [Related]
13. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.
Ortéga N; Jonca F; Vincent S; Favard C; Ruchoux MM; Plouët J
Am J Pathol; 1997 Nov; 151(5):1215-24. PubMed ID: 9358746
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.
Guo D; Jia Q; Song HY; Warren RS; Donner DB
J Biol Chem; 1995 Mar; 270(12):6729-33. PubMed ID: 7896817
[TBL] [Abstract][Full Text] [Related]
15. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
16. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
[TBL] [Abstract][Full Text] [Related]
17. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
[TBL] [Abstract][Full Text] [Related]
18. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
Takahashi T; Shibuya M
Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
[TBL] [Abstract][Full Text] [Related]
20. Flk-1 as a target for tumor growth inhibition.
Strawn LM; McMahon G; App H; Schreck R; Kuchler WR; Longhi MP; Hui TH; Tang C; Levitzki A; Gazit A; Chen I; Keri G; Orfi L; Risau W; Flamme I; Ullrich A; Hirth KP; Shawver LK
Cancer Res; 1996 Aug; 56(15):3540-5. PubMed ID: 8758924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
